• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD IAG BC PRO GLOBAL; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD IAG BC PRO GLOBAL; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 381034
Medical Device Problem Code Defective Component (2292)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/22/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Event or Problem Description
It was reported that bd iag bc pro global catheter broke.The following information was provided by the initial reporter translated from french to english: when the catheter was inserted, the operator injected and then fitted the catheter.At this point, a piece of plastic came detached.Unfortunately, the device was thrown away.(b)(6); has there been any harm to patients/healthcare professionals? there is no damage to the patient, there is a rupture of the catheter for which it is necessary to make a change and perform double procedure to the patient.Could you share the photos of the incident? photographic evidence is added.Was there a need for medical and/or surgical intervention due to the incidence (imaging tests, surgery, drug administration, etc.)? (detail) it was not necessary.Was there exposure of blood/chemotherapy to mucous membranes (eyes, nose and mouth) or skin? if yes, indicate whether the exposure was from the patient or the professional and what measures were taken.(detail) there was no exposure.
 
Event or Problem Description
No additional information.
 
Additional Manufacturer Narrative
Investigation results: a device history record review was completed by our quality engineer team for provided material number 381034 and lot number 4116718.The review did not reveal any detected abnormalities during the production process that could have contributed to this defect and all quality tests were found to be within specification.As a sample was unavailable for return, a thorough sample investigation could not be completed.Based on the investigation results, an exact cause for this incident could not be identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD IAG BC PRO GLOBAL
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key20855150
Report Number1710034-2024-01440
Device Sequence Number8776245
Product Code FOZ
UDI-Device Identifier00382903810345
UDI-Public(01)00382903810345(11)240426(17)270430(10)4116718
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
UNK
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Pharmacist
Type of Report Initial,Followup
Report Date (Section B) 12/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number381034
Device Lot Number4116718
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/15/2024
Supplement Date Received by Manufacturer12/12/2024
Initial Report FDA Received Date12/05/2024
Supplement Report FDA Received Date12/12/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/26/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-